Fibrinogen and fibrin - proteins with complex roles in hemostasis and thrombosis

Clinical Hemorheology and Microcirculation

Volumn 16, Issue 4, 1996, Pages 383-477

  Blombäck, Birger ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biosynthesis; Evolution; Fibrin; Fibrinogen; Gel formation; Proteolysis; Thrombin

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 13A; COMPLEMENTARY DNA; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STAPHYLOKINASE; STREPTOKINASE; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; UROKINASE;

AFIBRINOGENEMIA; BINDING SITE; BIOSYNTHESIS; DISULFIDE BOND; DYSFIBRINOGENEMIA; EVOLUTION; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; THROMBOGENESIS; THROMBOSIS;

EID: 0029819922     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-1996-16401     Document Type: Article

References (442)

1. BAILEY, K", BETTELHEIM, F.R., LORAND, L. and MIDDLEBROOK, W.R. Action of thrombin in the clotting of fibrinogen. Nature 167, 233-234, 1951.
2. BAILEY, K. and BETTELHEIM, F.R. The clotting of fibrinogen. I. The liberation of peptide material. Biochim Biophys Acta 18, 495-503, 1955.
3. SCHERAGA, H.A. and LASKOWSKI, M., Jr. The fibrinogen-fibrin conversion. Adv Protein Chem 72, 1-131, 1957.
4. BLOMBÄCK, B. Fibrinogen to fibrin transformation. In: Blood Clotting Enzymology. W.H. Seegers (Ed.), pp. 143-215, Academic Press Inc., New York 1967.
5. LAKI, K. Introduction and summary. In: Fibrinogen. K. Laki (Ed), pp. 1-24, Marcel Dekker Inc., New York 1968.
6. DOOLITTLE, R.F. Fibrinogen and fibrin. Ann Rev Biochem 53, 195-229, 1984.
7. FURLAN, M. Structure and function of normal fibrinogen. In: Variants of human fibrinogen. E.A. Beck and M. Furlan (Eds), pp. 38-63, Hans Huber Publishers 1984.
8. CRABTREE, G.R. The molecular biology of fibrinogen. In: The Molecular Basis of Blood Diseases G. Stamatoyannopoulos, A.W. Nienhuis, P. Leder, P.W. Majerus (Eds.), pp. 631-661, W.B. Saunders Comp., Philadelphia 1987.
9. CASPARY, E.A. and KEKWICK, R.A. Some physicochemical properties of human fibrinogen. Biochem J 67, 41-48, 1957.
10. FU, Y., WEISSBACH, L., PLANT, P.W., ODDOUX, C, CAO, Y., LIANG, T.J., ROY, S.N., REDMAN, CM. and GRIENINGER, G. Carboxy-terminal-extended variant of the human fibrinogen a subunit: A novel exon conferring marked homology to ß and y subunits. Biochemistry 31, 11968-11972, 1992.
11. FU, Y. and GRIENINGER, G. FIB420: A normal human variant with two extended a chains. Proc Natl Acad Sei USA 91, 2625-2628, 1994.
12. MARGUERIE, G. and STUHRMANN, H.B. A neutron small-angle scattering study of bovine fibrinogen. J Mol Biol 102, 143-156, 1976.
13. HALL, C.E. and SLAYTER, H.S. The fibrinogen molecule: Its size, shape and mode of polymerization. J Biophys Biochem Cytol 5, 11-17, 1959.
14. STRYER, L., COHEN, C. and LANGRIDGE, R. Axial period of fibrinogenand fibrin. Nature 797, 793-794, 1963.
15. TOONEY, N.M. and COHEN, C. Microcrystals of a modified fibrinogen. Nature 237, 23-25, 1972.
16. COHEN, C, WEISEL, J.W., PHILLIPS, G.N., Jr., STAUFFACHER, C.V., FILLERS, J.P. and DAUB, E. The structure of fibrinogen and fibrin: I. Electron microscopy and X-ray crystallography of fibrinogen. Ann NY Acad Sei 408, 194-213, 1983.
17. WEISEL, J.W., STAUFFACHER, C.V., BULLITT, E. and COHEN, C. A model for fibrinogen: Domains and sequence. Science 230, 1388-1391, 1985.
18. BACHMANN, L., SCHMITT-FUMIAN, W.W., HAMMEL, R. and LEDERER, K. Size and shape of fibrinogen. I. ELectron microscopy of the hydrated molecule. Macromol Chemie 176, 2603-2618, 1975.
19. MOSESSON, M.W. Fibrinogen heterogeneity. Ann NY Acad Sci 408, 97-113, 1983.
20. HOLM, B., NILSEN, D.W.T., KIERULF, P. and GODAL, H.C. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res 37, 165-176, 1985a.
21. HOLM, B., BROSSTAD, F., KIERULF, P. and GODAL, H.C. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the oc-chain is of importance for fibrin polymerization. Thromb Res 39, 595-606, 1985.
22. GAFFNEY, P.J. Structure of fibrinogen and degradation products of fibrinogen and fibrin. Br Med Bull 33, 245-252, 1977.
23. BACH-GANSMO, E.T., HALVORSEN, S., GODAL, H.C. and SKJONSBERG, O.H. Impaired coagulation of fibrinogen due to digestion of the C-terminal end of the A a-chain by human neutrophil elastases. Thromb Res 73, 61-68, 1994.
24. NOSSEL, H.L. Relative proteolysis of the fibrinogen Bp chain by thrombin and plasmin as a determinant of thrombosis. Nature 291, 165-167, 1981.
25. FINLAYSON, J.S. and MOSESSON, M.W. Heterogeneity of human fibrinogen. Biochemistry, 2, 42-46, 1963.
26. MOSHER, D.F. and BLOUT, E.R. Heterogeneity of bovine fibrinogen and fibrin. J Biol Chem 248, 6896-6903, 1973.
27. MOSESSON, M.W., FINLAYSON, J.S. and UMFLEET, R.A. Human fibrinogen heterogeneities. III. Identification of y chain variants. J Biol Chem 247, 5223-5227, 1972.
28. GAFFNEY, P.J. Localisation of carbohydrate in the subunits of human fibrinogen and its plasmin induced fragments. Biochim Biophys Acta 263, 453-458, 1972.
29. GATI, W.P. and STRAUB, P.W. Separation of both the Bβ -and the γ-polypeptide chains of human fibrinogen into two main types which differ in sialic acid content. J Biol Chem 253, 1315-1321, 1978.
30. EBERT, R.F. Index of variant human fibrinogens. CRC Press, Inc. Boca Raton, Ann Arbor, London, Tokyo 1994.
31. BLOMBACK, B. and YAMASHINA, I. On the N-terminal amino acids in fibrinogen and fibrin. Arkiv Kemi, 12, 299-319, 1958.
32. BLOMBACK, B., BLOMBACK, M., HENSCHEN, A., HESSEL, B., IWANAGA, S. and WOODS, K.R. N-terminal disulphide knot of human fibrinogen. Nature, 218, 130-134, 1968.
33. BLOMBACK, B. The N-terminal disulphide knot of human fibrinogen. The Fourth Michael Cross Memorial Lecture, London. Brit J Haematol, 17, 145-157, 1969.
34. BLOMBACK, B., HESSEL, B. and HOGG, D. Disulfide bridges in NH2-terminal part of human fibrinogen. Thromb Res 8, 639-658, 1976.
35. HENS CHEN, A. Paper electrophoretic patterns and mobilities of unmodified, sulfitolyzed and reduced-alkylated fibrinogen and fibrin in buffered 6 M urea. Arkiv Kemi 22, 397-415, 1964.
36. MIYATA, T., TERUKINA, S., MATSUDA, M. KASAMATSU, A., TAKEDA, Y., MURAKAMI, T. and IWANAGA, S. Fibrinogens Kawaguchi and Osaka: An amino acid substitution of Aoc arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aa chains. J Biochem 102, 93-101, 1987.
37. HOEPRICH, H.D. and DOOLITTLE, R.F. Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry 22, 2049-2055, 1983.
38. HENSCHEN, A., LOTTSPECH, F., KEHL, M., SOUTHAN, D. and LUCAS, J. Structure-function-evolution relationship in fibrinogen. In: Fibrinogen-Recent biochemical and medical aspects. A: Henschen, H. Graeff and F. Lottspech (Eds), pp. 67-82, Walter de Gruyter & Co., Berlin-New York 1982.
39. HENSCHEN, A., LOTTSPEICH, F., KEHL, M. and SOUTHAN, C. Covalent structure of fibrinogen. Ann NY Acad Sci 408, 28-43, 1983.
40. DOOLITTLE, R.F. The structure and evolution of vertebrate fibrinogen. Ann NY Acad Sci 408, 13-27, 1983.
41. WATT, K.W.K., COTTRELL, B.A., STRONG, D.D. and DOOLITTLE, R.F. Amino acid sequence studies on the a chain of human fibrinogen. Overlapping sequences providing the complete sequence. Biochemistry 18, 5410-5416, 1979.
42. KANT, J.A., LORD, S.T. and CRABTREE, J.R. Partial mRNA sequences for human Aa, Bp, and y fibrinogen chains: Evolutionary and functional implications. Proc Natl Acad Sci USA 80, 3953-3957, 1983.
43. WOLFENSTEIN-TODEL, C. and MOSESSON, M.W. Carboxy-terminal amino acid sequence of a human fibrinogen y-chain variant (y’). Biochemistry 20, 6146-6149, 1981.
44. CRABTREE, G.R. and KANT, J.A. Organization of the rat gamma-fibrinogen gene: alternative mRNA splice patterns produce the gamma A and gamma B (gamma ') chains of fibrinogen. Cell 31, 159-166, 1982.
45. FORNACE, A.J. Jr., CUMMINGS, D.E., COMEAU, CM., KANT, J.A. and CRABTREE, G.R. Structure of the human y-fibrinogen gene. J Biol Chem 259, 12826-12830, 1984.
46. FRANCIS, C.W., MULLER, E., HENSCHEN, A., SIMPSON, P.J. and MARDER. V.J. Carboxyl-terminal amino acid sequences of two variant forms of the y chain of human plasma fibrinogen. Proc Natl Acad Sci USA 85, 3358-3362, 1988.
47. SEYDEWITZ, H.H. and WITT, I. Increased phosphorylation of human fibrinopeptide A under acute phase conditions. Thromb Res 40, 29-39, 1985.
48. KRAJEWSKI, T. and BLOMBACK, B. The location of tyrosine-o-sulphate in fibrinopeptides. Acta Chem. Scand. 22, 1339-1346, 1968.
49. JEVONS, F.R. Tyrosine O-sulphate in fibrinogen and fibrin. Biochem J 89, 621-624, 1963.
50. FARRELL, D.H., MULVIHILL, E.R., HUANG, S., CHUNG, D.W. and DAVIE, E.W. Recombinant human fibrinogen and sulfation of the y’ chain. Biochemistry 30, 9414-9420, 1991.
51. TOWNSEND, R.R., HILLIKER, E., LI, Y.-T., LAINE, R.A., BELL, W.R. and LEE, Y.C. Carbohydrate structure of human fibrinoge. Use of 300-MHz *H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem 257, 9704-9710, 1982.
52. MESTER, L. Structure and the role of carbohydrate fractions of glycoproteins implicated in blood coagulation. Bull Soc Chim Biol 57, 635-648, 1969.
53. BLOMBACK, B., GRONDAHL, N.J., HESSEL, B., IWANAGA, S. and WALLEN, P. Primary structure of human fibrinogen and fibrin. J Biol Chem, 248, 5806-5820, 1973.
54. WATT, K.W.K., TAKAGI, T. and DOOLITTLE, R.F. Amino acid sequence of the j3 chain of human fibrinogen. Biochemistry 18, 68-76, 1979.
55. EVERSE, S.J., PELLETIER, H. and DOOLITTLE, R.F. Crystallization of fragment D from human fibrinogen. Protein Sci 4, 1013-1016, 1995.
56. GARDLUND, B., HESSEL, B., MARGUERIE, G., MURANO, G. and BLOMBACK, B. Chemical characterization of disulfide containing cyanogen bromide fragments. Eur J Biochem 77, 595-610, 1977.
57. BLOMBACK, B., BLOMBACK, M., OLSSON, P., SVENDSEN, L. and ABERG, G. Synthetic peptides with anticoagulant and vasodilating activity. Scand J Clin Lab Inv 24, Suppl. 107, 59-64, 1969.
58. BLOMBACK, B., BLOMBACK, M., FINKBEINER, W., HOLMGREN, A., KOWALSKA-LOTH, B. and OLOVSON, G. Enzymatic reduction of disulfide bonds in fibrinogen by the thioredoxin system. I. Identification of reduced bonds and studies on reoxidation process. Thromb. Res. 4, 55-75, 1974.
59. PROCYK, R. and BLOMBACK, B. Disulfide bond reduction in fibrinogen: Calcium protection and effect on clottability. Biochemistry 29, 1501-1507, 1990.
60. PROCYK, R., MEDVED, L., ENGELKE, K.J., KUDRYK, B. and BLOMBACK, B. Nonclottable fibrin obtained from partially reduced fibrinogen: Characterization and tissue plasminogen activator stimulation. Biochemistry 31, 2273-2278, 1992.
61. ZHANG, J.-Z. and REDMAN, CM. Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. J Biol Chem 269, 652-658, 1994.
62. HUANG, S., CAO, Z. and DAVIE, E.W. The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen. Biochem Biophys Res Commun 190, 488-495, 1993.
63. BOUMA, H. Ill, TAKAGI, T. and DOOLITTLE, R.F. The arrangement of disulfide bonds in fragment D from human fibrinogen. Thromb Res 13, 557-562, 1978.
64. DOOLITTLE, R.F., GOLDBAUM, D.M. and DOOLITTLE, L.R. Designation of sequences involved in the "coiled coil" interdomanial connections in fibrinogen: Construction of an atomic scale model. J Mol Biol 120, 311-325, 1978.
65. KOWALSKA-LOTH, B., GARDLUND, B., EGBERG, N. and BLOMBACK, B. Plasmic degradation products of human fibrinogen. II. Chemical and immunological relation between fragment E and N-DSK. Thromb Res, 2, 423-450, 1973.
66. COLLEN, D., KUDRYK, B., HESSEL, B. and BLOMBACK, B. Primary structure of human fibrinogen and fibrin. III. Isolation and partial characterization of chains of fragment D. J Biol Chem 250, 5808-5817, 1975.
67. GARDLUND, B. Human fibrinogen-amino acid sequence of fragment E and of adjacent structures in the Aa-and Bp-chains. Thromb Res 10, 689-702, 1977.
68. DOOLITTLE, R.F., WATT, K.W.K., COTTRELL, B.A., STRONG, D.D, and RILEY, M. The amino acid sequence of the a-chain of human fibrinogen. Nature 280, 464-468, 1979.
69. BLOMBACK, B., HESSEL, B., HOGG, D. and THERKILDSEN, L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 257, 501-505, 1978.
70. BLOMBACK, B. and VESTERMARK, A. Isolation of fibrinopeptides by chromatography. Arkiv Kemi 12, 173-182, 1958.
71. BLOMBACK, B., OKADA, M., FORSLIND, B. and LARS SON, U. Fibrin gels as biological filters and interfaces. Biorheology 21, 93-104, 1984.
72. SHAINOFF, J.R., SMEJKAL, G.B., DiBELLO, P.M., BULLOCH, R.E., LEVY, P.J., JANG, Y. and LILL, H. A non-aggregating fibrin-precursor identified in abnormal plasmas and thrombin reactions. Thromb Haemostas 73, pp. 1225, 1242 Abs., 1995.
73. MEH, D.A., SIEBENLIST, K.R., BERGTROM, G. and MOSESSON, M.M. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin. J Lab Clin Med 125, 384-391, 1995.
74. BLOMBACK, B. and OKADA, M. Fibrin gel structure and clotting time. Thromb Res 25, 51-70, 1982.
75. OKADA, M. and BLOMBACK, B. Calcium and fibrin gel structure. Thromb Res 29, 269-280, 1983.
76. BARK, N., BLOMBACK, B. and FATAH, K. On the occurrence of thrombin-like enzymes in mosquitoes. Thromb Res 81, 623-634, 1996.
77. WEISEL, J.W. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J 50, 1079-1093, 1986.
78. WEISEL, J.W., VEKLICH, Y. and GORKUN, O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 232, 285-297, 1993.
79. BLOMBÄCK, B. Fibrinogen and fibrin formation. In: Handbuch der Experimentellen Pharmakologie. Vol. 46. Fibrinolytics and antifibrinolytics. F. Markwardt (Ed.), pp. 49-79. Springer Verlag, Berlin, Heidelberg 1978.
80. HOGG, D.H. and BLOMBÄCK, B. The mechanism of the fibrinogen-thrombin reaction. Thromb. Res. 12, 953-964, 1978.
81. SIEBENLIST, K.R., DiORIO, J.P., BUDZYNSKI, A.Z. and MOSESSON, M.W. The polymerization and thrombin-binding properties of Des-(Bß21-42)-fibrin. J Biol Chem 265, 18650-18655, 1990.
82. BLOMBÄCK, B., BLOMBÄCK, M., GRÖNDAHL, N.J. and HOLMBERG, E. Structure of fibrinopeptides-its relation to enzyme specificity and phylogeny and classification of species. Arkiv Kemi 25, 411-428, 1966.
83. SEEGERS, W.H., NIEFT, M. and LOOMIS, E.C. Note on the adsorption of thrombin on fibrin. Science 101, 520-521, 1945.
84. CLAESON, G. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system. Blood Coag Fibrinol 5, 411-436, 1994.
85. SCHERAGA, H.A. In: Chemistry and Biology of Thrombin. R.L Lundblad, J.W. Fenton, II and K.G. Mann (Eds.) pp. 145-??, Ann Arbor Science Publishers, Michigan 1977.
86. MEINWALD, Y.C., MARTINELLI, R.A., VAN NISPEN, J.W. and SCHERAGA, H.A. Mechanism of action of thrombin on fibrinogen. Size of the Aa fibrinogen-like peptide that contacts the active site of thrombin. Biochemistry 19, 3820-3825, 1980.
87. MARSH, H.C, Jr., MEINWALD, Y.C, THANNHAUSER, T.W. and SCHERAGA, H.A. Mechanism of action of thrombin on fibrinogen. Kinetic evidence for involvement of aspartic acid at position Pio. Biochemistry 22, 4170-4174, 1983.
88. NI, F., KONISHI, Y., FRAZIER, R.B., SCHERAGA, H.A. and LORD, S.T. High-resolution NMR studies of fibrinogen-like peptides in solution: Interaction of thrombin with residues 1-23 of the Aa chain of human fibrinogen. Biochemistry 28, 3082-3094, 1989.
89. NI, F., MEINWALD, Y.C, VASQUEZ, M. and SCHERAGA, H.A. High-resolution NMR studies of fibrinogen-like peptides in solution: Structure of a thrombin-bound peptide corresponding to residues 7-16 of the Aa chain of human fibrinogen. Biochemistry 28, 3094-3105, 1989.
90. NI, F., KONISHI, Y., BULLOCK, L.D., RIVETNA, M.N. and SCHERAGA, H.A. High-resolution NMR studies of fibrinogen-like peptides in solution: Structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the Aa chain of human fibrinogen Rouen. Biochemistry 28, 3106-3119, 1989.
91. LORD, S.T., BYRD, P.A., HEDE, K.L. WEI, D.C. and COLBY, T.J. Analysis of fibrinogen Aa-fusion proteins. Mutants which inhibit thrombin equivalently are not equally good substrates. J Biol Chem 265, 838-843, 1990.
92. STUBBS, M.T., OSCHKINAT, H., MAYR, I. HUBER, R., ANGLIKER, H., STONE, S.R. and BODE, W. The interaction of thrombin with fibrinogen. -A structural basis for its specificity. Eur J Biochem 206, 187-195, 1992.
93. STUBBS, M.T. and BODE, W. A player of many parts: The Spotlight falls on thrombin’s structure. Thromb Res 69, 1-58, 1993.
94. MARTIN, P.D., ROBERTSON, W., TURK, D., HUBER, R., BODE, W. and EDWARDS, B.F.P. The structure of residues 7-16 of the Aa-chain of human fibrinogen bound to bovine thrombin at 2.3Ä resolution. J Biol Chem 267, 7911-7920, 1992.
95. LIU, C.Y., NOSSEL, H.L. and KAPLAN, K.L. The binding of thrombin by fibrin. J Biol Chem 254, 10421-10425, 1979.
96. FENTON, J.W. II, OLSON, T.A., ZABINSKI, M.P. and WILNER, G.D. Anion-binding exosite of human a-thrombin and fibrin(ogen) recognition. Biochemistry 27, 7106-7112, 1988.
97. BERLINER, L.J., SUGAWARA, Y. and FENTION, J.W., II. Human a-thrombin binding to nonpolymerized fibrin-Sepharose: Evidence for an anionic binding region. Biochemistry 24, 7005-7009, 1985.
98. KACZMARECK, E. and McDONAGH, J. Thrombin binding to the Aa, Bß and y-chains of fibrinogen and to their remnants contained in fragment E. J Biol Chem 263, 13896-13900, 1988.
99. VALI, Z. and SCHERAGA, H.A. Localizsation of the binding site on fibrin for the secondary binding site of thrombin. Biochemistry 27, 1956-1963, 1988.
100. BINNIE, CG. and LORD, S.T. A synthetic analogue of fibrinogen a27-50 is an inhibitor of thrombin. Thromb Haemost 65, 165-168, 1991.
101. FERRY, J.D. The mechanism of polymerization of fibrinogen. Proc Natl Acad Sci USA 38, 566-569, 1952.
102. ERICKSON, H.P. and FOWLER, W.E. Electron microscopy of fibrinogen, its plasmic fragments and small polymers. Ann NY Acad Sci 408, 146-163, 1983.
103. LAURENT, T.C. and BLOMBÄCK, B. On the significance of the release of two different peptides from fibrinogen during clotting. Acta Chem Scand 12, 1875-1877, 1958.
104. HEENE, D.L. and MATTHIAS, F.R. Adsorption of fibrinogen derivatives on insolubilized fibrinogen and fibrin monomers. Thromb Res 2, 137-154, 1973.
105. BLOMBÄCK, M., BLOMBÄCK, B., MAMMEN, E.F. and PRASAD, A.S. Fibrinogen Detroit-a molecular defect in the N-terminal disulphide knot of human fibrinogen. Nature 218, 134-137, 1968.
106. SÖDERQVIST, T. and BLOMBÄCK, B. Fibrinogen structure and evolution. Naturwissenschaften 58, 16-23, 1971.
107. BLOMBÄCK, B. and BLOMBÄCK, M. The molecular structure of fibrinoge. In: The biological role of the clot stabilizing enzymes: transglutaminase and factor XHL Conference, N.Y. November 1971. K. Laki (Ed). Ann NY Acad Sci 202, 77-97, 1972.
108. KUDRYK, B., REUTERBY, J. and BLOMBÄCK, B. Adsorption of plasmic fragment D to thrombin modified fibrinogen-Sepharose. Thromb. Res. 2, 423-450, 1973.
109. KUDRYK, B.J., COLLEN, D., WOODS, K.R. and BLOMBÄCK, B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 249, 3322-3325, 1974.
110. YORK, L.L. and BLOMBÄCK, B. Interaction of fragments of fibrinogen with insolubilized fibrin monomers (activated fibrinogen). Thromb Res 8, 607-618, 1976.
111. KUDRYK, B., BLOMBÄCK, B. and BLOMBÄCK, M. Fibrinogen Detroit-an abnormal fibrinogen with non-functional NH2-terminal polymerization domain. Thromb Res 9, 25-36, 1976.
112. LAUDANO, A.P. and DOOLITTLE, R.F. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 19, 1013-1019, 1978.
113. LAUDANO, A.P. and DOOLITTLE, R.F. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization to fibrin monomers. Proc. Natl. Acad. Sci. USA 75, 3085-3089, 1978.
114. LAUDANO, A.P., COTTRELL, B.A. and DOOLITTLE, R.F. Synthetic peptides modeled on fibrin polymerization sites. Ann NY Acad Sci 408, 315-329, 1983.
115. DRAY-ATTALI, L. and LARRIEU, MJ. Fragments D-correlation between structure and biological activity. Thromb Res 10, 575-586, 1977.
116. BUDZYNSKI, A.Z., OLEXA, S.A. and PANDYA, B.V. Fibrinogen polymerization sites in fibrinogen and fibrin fragments. Ann NY Acad Sci 408, 301-314, 1983.
117. OLEXA, S.A. and BUDZYNSKI, A.Z. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 77, 1374-1378, 1980.
118. OLEXA, S.A. and BUDZYNSKI, A.Z. Localization of a fibrin polymerization site. J Biol Chem 256, 3544-3549, 1981.
119. VARADI, A. and SCHERAGA, H.A. Localization of segments essential for polymerization and for calcium binding in the y-chain of human fibrinogen. Biochemistry 25, 519-528, 1986.
120. SHIMIZU, A., NAGEL, G.M. and DOOLITTLE, R.F. Photoaffinity labeling of the primary polymerization site: Isolation and characterization of a labeled cyanogen bromide fragment corresponding to y-chain residues 337-379. Proc Natl Acad Sci USA 89, 2888-2892, 1992.
121. YAMAZUMI, K. and DOOLITTLE, R.F. Photoaffinity labeling of the primary fibrin polymerization site: Location of the label to y-chain Tyr-363. Proc Natl Acad Sci USA 89, 2893-2896, 1992.
122. BUDZYNSKI, A.Z., STAHL, M., KOPEC, M., LATALLO, Z.S., WEGRZYNOWICZ, Z. and KOWALSKI, E. High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation with the fibrinogen molecule. Biochim Biophys Acta 147, 313-323, 1967.
123. MIHALYI, E. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B. Biochemistry 27, 967-976, 1988.
124. MIHALYI, E. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations. Biochemistry 27, 976-982, 1988.
125. MIHALYI, E., TERCERO, J.C. and DIAZ-MAURINO, T. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation pH change with the release of fibrinopeptides and the ensueing polymerization. Biochemistry 30, 4753-4762, 1991.
126. BLOMBÄCK, B., HESSEL, B., FIELDS, R. and PROCYK, R. Fibrinogen Aarhus: An abnormal fibrinogen with Accl9Arg->Gly substitution. In: Fibrinogen 3. Biochemistry, biological functions, gene regulation and expression. M.W. Mosesson et al. (Eds.), pp. 263-266, Elsevier Science Publ. B.V. Biomedical Division, Amsterdam 1988.
127. BLOMBÄCK, B. Studies on the action of thrombic enzymes on bovine fibrinogen as measured by N-terminal analysis. Arkiv Kemi 12, 321-335, 1958.
128. HASEGAWA, N. and SASAKI, S. Location of the binding site "b" for lateral polymerization of fibrin. Thromb Res 57, 183-195, 1990.
129. SHAINOFF, J.R. and DARDIK, B.N. Fibrinopeptide B and aggregation of fibrinogen. Science 204, 200-202, 1979.
130. SHAINOFF, J.R. and DARDIK, B.N. Fibrinopeptide B in fibrin assembly and metabolism. Physiologic significance in delayed release of the peptide. Ann N.Y. Acad Sci 408, 254-268, 1983.
131. DYR, J.E., BLOMBÄCK, B., HESSEL, B. and KORNALIK, F. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. Biochim Biophys Acta 990, 18-24, 1989.
132. WEISEL, J.W., FRANCIS, C.W., NAGASWAMI, C. and MARDER, V.J. Determination of the topology of factor XHIa-induced fibrin y-chain cross-links by electron microscopy of ligated fragments. J Biol Chem 268, 26618-26624, 1993.
133. BLOMBÄCK, B., CARLSSON, K., FATAH, K., HESSEL, B. and PROCYK, R. Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 75, 521-538, 1994.
134. WEISEL, J.W., NAGASWAMI, C. and MAKOWSKI, L. Twisting of fibrin fibers limits their radial growth. Proc Natl Acad Sci, USA 84, 8991-8995, 1987.
135. MEDVED, L.V. Relationship between exons and domains in the fibrinogen molecule. Blood Coagul Fibrinol 1, 439-442, 1990.
136. VEKLICH, Y.I., GORKUN, O.V., MEDVED, L.V., NIEUWENHUIZEN, W. and WEISEL, J.W. Carboxy-terminal portions of the a-chains of fibrinogen and fibrin. Localisation by electron microscopy and the effects of isolated aC fragments on polymerization. J Biol Chem, 268, 13577-13585, 1993.
137. GORKUN, O.V., VEKLICH, Y.I., MEDVED, L.V., HENSCHEN, A.H. and WEISEL, J.W. Role of alpha C domains of fibrin in clot formation. Biochemistry 33, 6986-6998, 1994.
138. HESSEL, B., BLOMBÄCK, B. and SÖDERMAN, S. Fibrin formation in presence of trypsin. In: Fibrinogen-Recent Biochemical and Medical Aspects, pp. 101-108. A. Henschen, H. Graeff, F. Lottspeich (Eds). Walter de Gruyter & Co., Berlin-New York 1982.
139. RUDCHENKO, S., TRAKHT, I. and SOBEL, J.H. Comparative structure and functional features of the human fibrinogen alpha C domain and the isolated alpha C fragment. Characterization using monoclonal antibodies to defined COOH-terminal A alpha chain regions. J Biol Chem 277, 2523-2530, 1996.
140. WEISEL, J.W. AND PAPSUN, D.M. Involvement of the COOH-terminal portion of the alpha-chain of fibrin in the branching of fibers to form a clot. Thromb Res 47, 155-163, 1987.
141. KUDRYK, B., BINI, A., PROCYK, R. MATSUEDA, G.R. and SHAINOFF, J.R. Cross-linking of fibrinogen by tissue transglutaminase: involvement of the C-termini of the A a-and y-chain in formation of Aay-dyads. Thromb Haemost 69, 2560 Abs., 1993.
142. BLOMBÄCK, B., ADAMSON, L., HESSEL, B., HOLMGREN, A., HOGG, D. and PROCYK, R. The effect of thioredoxin system and thiols on some coaguloproteins. In: Thioredoxin and Glutaredoxin Systems; structure and function. A. Holmgren, C.-I. Bränden, H. Jörnvall and B.-M. Sjöberg (Eds.), pp. 357-367, Raven Press, N.Y. 1986
143. ZHANG, J.-Z. and REDMAN, CM. Identification of Bß chain domains involved in human fibrinogen assembly. J Biol Chem 267, 21727-21732, 1992.
144. ZHANG, J.-Z., KUDRYK, B. and REDMAN, CM. Symmetrical disulfide bonds are not necessary for assembly and secretion of human fibrinogen. J Biol Chem 268, 11278-11282, 1993.
145. LOEWY, A.G. Some thoughts on the state in nature, biosynthetic origin and function of factor XIII. Ann NY Acad Sci 202, 41-58, 1972.
146. LORAND, L. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma. Ann NY Acad Sci 202, 6-30, 1972.
147. DOOLITTLE, R.F., CASSMAN, K.G., CHEN, R., SHARP, JJ. and WOODING, G.L. Correlation of the mode of fibrin polymerization with pattern of cross-linking. Ann NY Acad Sci 202, 114-126, 1972.
148. McKEE, P.A., SCHWARTZ, M.L., PIZZO, S.V. and HILL, R.L. Cross-linking of fibrin by fibrin-stabilizing factor. Ann N.Y. Acad Sci 202, 127-148, 1972.
149. PISANO, J.J., BRONZERT, T.J., PEYTON, M.P. and FINLAYSON, J.S. e (y-glutamyl) lysine cross-links: Determination in fibrin from normal and factor XHI-deficient individuals. Ann NY Acad Sci 202, 98-113, 1972.
150. SIEBENLIST, K.R., MEH, D.A., WALL, J.S., HAINFELD, J.F. and MOSESSON, M.W. Orientation of the carboxy-terminal regions of fibrin y chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D and factor XHIa. Thromb Haemost 74, 1113-1119, 1995.
151. MOSESSON, M.W., SIEBENLIST, K.R., AMRANI, D.L. and DiORIO, J.P. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. Proc Natl Acad Sci USA 86, 1113-1117, 1989.
152. SIEBENLIST, K.R. and MOSESSON, M.W. Factors affecting y-chain multimer formation in cross-linked fibrin. Biochemistry 31, 936-941, 1992.
153. KAN AIDE, H. and SHAINOFF, J.R. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XHIa). J Lab Clin Med 85, 574-597, 1975.
154. COTTRELL, B.A., STRONG, D.D., WATT, K.V. and DOOLITTLE, R.F. Amino acid sequence studies on the a chain of human fibrinogen. Exact location of cross-linking acceptor sites. Biochemistry 18, 5405-5410, 1979.
155. LY, B., KIERULF, P. and JAKOBSEN, E. Stabilization of soluble fibrin/fibrinogen complexes by fibrin stabilizing factor (FSF). Thromb Res 4, 509-522, 1974.
156. SOBEL, J.H., THIBODEAU, C.A. and CANFIELD, R.E. Early alpha chain crosslinking in human fibrin preparations. Thromb Haemost 60, 153-159, 1988.
157. SHAINOFF, J.R., URBANIC, D.A. and DiBELLO, P.M. Immunoelectrophoretic characterization of the cross-linking of fibrinogen and fibrin by factor XHIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. J Biol Chem 266, 6429-6437, 1991.
158. MURTHY, S.N., WILSON, J., GUY, S.L. and LORAND, L. Intramolecular cross-linking of monomeric fibrinogen by tissue transglutaminase. Proc Natl Acad Sci USA 88, 10601-10604, 1991.
159. GRoN, B., FILION-MYKLEBUST, C, BENNICK, A., NIEUWENHUIZEN, W., MATSUEDA, G.R. and BROSSTAD, F. Early cross-linked fibrin in human plasma contains a-polymers with intact fibrinopeptide A. Blood Coagul Fibrinol 3, 731-736, 1992.
160. GRoN, B., FILION-MYKLEBUST, C, BJORNSEN, S., HAIDARIS, P. and BROSSTAD, F. Cross-linked ocs-yt-chain hybrids in plasma clots studied by ID and 2D electrophoresis and Western blotting. Thromb Haemost 70, 438-442, 1993.
161. KRAKOW, W., ENDRES, G.F., SIEGEL, B.M. and SCHERAGA, H.A. An electron microscopic investigation of the polymerization of bovine fibrin monomer. J Mol Biol 71, 95-103, 1972.
162. WILLIAMS, R.C. Morphology of fibrinogen monomers and fibrin protofibrils. Ann NY Acad Sci 408, 180-193, 1983.
163. HANTGAN, R.R and HERMANS, J. Assembly of fibrin. A light scattering study. J Biol Chem 254, 11272-11281, 1979.
164. PORTER, K.R. and HAWN, C.v.Z. Sequences in the formation of clots from purified bovine fibrinogen and thrombin: A study with the electron microscope. J Exp Med 90, 225-232, 1949.
165. SHAH, G.A., FERGUSON, I.A., DHALL, T.Z. and DHALL, D.P. Polydispersion in the diameter of fibres in fibrin networks: Consequences on the measurement of mass-length ratio by permeability and turbidity. Biopolymers 21, 1037-1047, 1982.
166. MÜLLER, M.F., RIS, H. and FERRY, J.D. Electron microscopy of fine fibrin clots and fine and coarse fibrin films. Observations of fibers in cross-section and in deformed states. J Mol Biol 174, 369-384, 1984.
167. MOSESSON, M.W., DiORIO, J.P., MÜLLER, M.F., SHAINOFF, J.R., SIEBENLIST, K.R., AMRANI, D.L., HOMANDBERG, G.A., SORIA, J., SORIA, C. and SAMAMA, M. Studies on the ultra structure of fibrin lacking fibrinopeptide B (ß-fibrin). Blood 69, 1073-1081, 1987.
168. FERRY, J.D. and MORRISON, P.R. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J Amer Chem Soc 69, 388-400, 1947.
169. CARR, M.E., Jr. and HERMANS, J. Size and density of fibrin fibers from turbidity. Macromolecules 11, 46-50, 1978.
170. CARR, M.E. and GABRIEL, D.A. Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 13, 1473-1477, 1980.
171. BLOMBÄCK, B CARLSSON, K., HESSEL, B., LILJEBORG, A., PROCYK, R., and ÄSLUND, N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 997, 96-110, 1989.
172. OKADA, ML, BLOMBÄCK, B. and BLOCK, M. Effect of albumin and dextran on fibrin gel structure. Thromb Haemost 50, 201, Abstract 613, 1983.
173. WAUGH, D.F. Protein-Protein Interactions. Advan Protein Chem 9, 325-437, 1954.
174. LAURENT, T.C. An early look at macromolecular crowding. Biophysical Chemistry 57, 7-14, 1995.
175. MARX, G. Elasticity of fibrin and protofibrin gels is differentially modulated by calcium and zinc. Thromb Haemost 59, 500-503, 1988.
176. OKADA, M., BLOMBÄCK, B., CHANG MING-DER and HOROWITZ, B. Fibronectin and fibrin gel structure. J Biol Chem 260, 1811-1820, 1985.
177. ROBERTS, W.W., KRAMER, O., ROSSER, R.W., NESTLER, F.H.M. and FERRY, J.D. Rheology of fibrin clots. I. Dynamic viscoelastic properties and fluid permeation. Biophys Chem 7, 152-160, 1974.
178. CARR, M.E., SHEN, L.L. and HERMANS, J. A physical standard of fibrinogen: Measurement of the elastic modulus of dilute fibrin gels with a new elastometer. Analyt Biochem 72, 202-211, 1976.
179. SHEN, L.L., HERMANS, J., McDONAGH, J. and McDONAGH, R.P. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod. Am J Physiol 232, H629-633, 1977.
180. SHEN, L.L., McDONAGH, R.P., McDONAGH, J. and HERMANS, J. Early events in the plasmin digestion of fibrinogen and fibrin. Effects of plasmin on fibrin polymerization. J Biol Chem, 252, 6184-6189, 1977.
181. SHAH, G.A., NAIR, C.H. and DHALL, D.P. Comparison of fibrin networks in plasma and fibrinogen solution. Thromb Res 45, 257-264, 1987.
182. LARSSON, U., BLOMBÄCK, B. and RIEGLER, R. Fibrinogen and the early stages of polymerization to fibrin as studied by dynamic laser light scattering. Biochim Biophys Acta 975, 172-179, 1987.
183. BACH-GANSMO, E.T., HALVORSEN, S., GODAL, H.C. and SKJONSBERG, O.H. Degradation of the a-chain of fibrin by human neutrophil elastase reduces the stimulating effect of fibrin on plasminogen activation. Thromb Res 75, 307-317, 1994b.
184. BINI, A., CALLENDER, S., PROCYK, R., BLOMBÄCK, B. and KUDRYK, B.J. Flow and antibody binding properties of hydrated fibrins prepared from plasma, platelet rich plasma and whole blood. Thromb Res 76, 145-156, 1994.
185. MARX, G. Modeling cation-driven (proto)fibrin coagulation. Biopolymers 29, 1233-1241, 1990.
186. HUNZIKER, E.B., STRAUB, P.W. and HAEBERLI, A. A new concept of fibrin formation based upon the linear growth of interlacing and branching polymers and molecular alignment into interlocked single-stranded segments. J Biol Chem 265, 7455-7463, 1990.
187. MEGA, J.I., SHAINOFF, J.R. and DRESHAR, D.A. Dissociation of oc-fibrin at elevated temperatures. In: Fibrinogen 3. Biochemistry, Biological functions, Gene Regulation and Expression. M.W. Mosesson, D.L. Amrani, K.R. Siebenlist and J.P. DiOrio (Eds), pp 83-86. Elsevier Science, Amsterdam 1988.
188. BECKER, CM. Bovine fibrinogen aggregates: Electron microscopic observations of quasi-globular structures. Thromb Res 48, 101-110, 1987.
189. BROSSTAD, F., KIERULF, P. and GODAL, H.C. The fibrin-solubilizing effect of fibrinogen as studied by light scattering. Thromb Res 14, 705-712, 1979.
190. MIHALYI, E. Kinetics and molecular mechanism of the proteolytic fragmentation of fibrinogen. Ann NY Acad Sci 408, 60-70, 1983.
191. NUSSENZWEIG, V., SELIGMANN, M., PELMONT, J. and GRABAR, P. Les produits de degradation du fibrinogène humain par la plasmine. I. Separation et propriétés physico-chemiques. Ann Inst Pasteur 100, 377-388, 1961.
192. MARDER, V.J., SHULMAN, N.R. and CARROLL, W.R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem 244, 2111-2119, 1969.
193. NY, T., PENG, X.-R. and OHLSSON, M. Hormonal regulation of the fibrinolytic components in the ovary. Thromb Res 71, 1-45, 1993.
194. WALLEN, P. Biochemistry of plasminogen. In: Fibrinolysis. D. Kline and K.N.N. Reddy (Eds.), pp 1-24, CRC Press, Boca Raton, FL. 1980.
195. THORSEN, S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation influence of co-aminocarboxylic acids. Biochim Biophys Acta 393, 55-65, 1975.
196. CEDERHOLM-WILLIAMS, S.A. The binding of plasminogen (Mol. WT. 84,000) and plasmin to fibrin. Thromb Res. 11, 421-423, 1977.
197. ADAMS LUCAS, M., FRETTO, L.J. and McKEE, P.A. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 258, 4249-4256, 1983.
198. DE SERRANO, V.S., URANO, T., GAFFNEY, P.J. and CASTELLINO, F.J. Influence of vaious structural domains of fibrinogen and fibrin on the poentiation of plasminogen activation by recombinant tissue plasminogen activator. J Prot Chem 8, 61-77, 1989.
199. SOTTRUP-JENSEN, L., CLAEYS, H., ZAJDEL, M., PETERSEN, T.E. and MAGNUSSON, S. ?? Check with Library. In: Progress in Chemical Fibrinlysis and Thrombolysis. Vol. 3. J.F. Davidson, R.M. Rowan, M.M. Samama and P.C. Desnayers (Eds.), pp. 191-209, Raven Press, N.Y. 1978.
200. SUENSON, E., LUTZEN, O. and THORSEN, S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 140, 513-522, 1984.
201. TRAN-THANG, C., KRUITHOF, E.K. and BACHMANN, F. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots. J Clin Invest 74, 2009-2016, 1984.
202. TRAN-THANG, C, KRUITHOF, E.K.O., ATKINSON, J. and BACHMAN, F. High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin. Eur J Biochem 160, 599-604, 1986.
203. SUENSON, E., BJERRUM, P., HOLM, A., LIND, B., MELDAL, M., SELMER; J. and PETERSEN, L.C. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. J Biol Chem 265, 22228-22237, 1990.
204. GARMAN, AJ. and SMITH, R.A.G. The binding of plasminogen to fibrin: Evidence of plasminogen-bridging. Thromb Res 27, 311-320, 1982.
205. WEISEL, J.W., NAGASWAMI, C, KORSHOLM, B., PETERSEN, L.C. and SUENSON, E. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. J Mol Biol 235, 1117-1135, 1994.
206. ASTRUP, T. and PERMIN, P.M. Fibrinolysis in the organism. Nature, 759, 681-683, 1947.
207. COLE, E.R. and BACHMAN, F.W. Purification and properties of plasminogen activator from pig heart. J Biol Chem 252, 3729-3737, 1977.
208. RIJKEN, D.C., WIJNGAARDS, G., ZAAL-DE JONG, M. and WELBERGEN, J. Purification and partial characterization of a plasminogen activator from human uterine tissue. Biochim Biophys Acta 580, 140-153, 1979.
209. WALLEN, P., RANBY, M., BERGSDORF, N. and KOK, P. Purification and characterization of tissue plasminogen activator: On the occurrence of two different forms and their enzymatic properties. In: Progress in Fibrinolysis. Vol. 5. J.F. Davidson, I.M. Nilsson, and B. Astedt (Eds), pp. 16-23, Churchill Livingstone, Edinburgh 1981.
210. WALLEN, P., BERGSDORF, N. and RANBY, M. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin. Biochim Biophys Acta 779, 318-328, 1982.
211. PENNICA, D., HOLMES, W.E., KOHR, W.J., HARKINS, R.N., VEHAR, G.A., WARD, C.A., BENNETT, W.F., YELVERTON, E., SEEBURG, P.H., HEYNEKER, H.L, GOEDDEL, D.V. and COLLEN, D. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301, 214-221, 1983.
212. WALLEN, P., POHL, G., BERGSDORF, N., RÄNBY, M., NY, T. and JÖRNVALL, H. Purification and characterization of a melanoma cell plasminogen activator. Eur J Biochem 132, 681-686, 1983.
213. CHENG, X.-F., BROHLIN, M., POHL, G., BÄCK, O. and WALLEN, P. Binding of tissue plasminogen activator to endothelial cells. Thromb Res 77, 149-164, 1995.
214. JÖRNVALL, H., POHL, G., BERGSDORF, N. and WALLEN, P. Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneity. FEBS Letter 156, 47-50, 1983.
215. CAMIOLO, S.M., THORSEN, S. and ASTRUP, T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc Soc Exp Biol Med 138, 277-280, 1971.
216. THORSEN, S., GLAS-GREENWALT, P. and ASTRUP, T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diath Haemorrh, 28, 65-74, 1972.
217. WALLEN, P. and WIMAN, B. Purification of tissue activator using affinity adsorption on fibrin and hydrophobic interaction chromatography. Effect of fibrin on the enzymatic properties of the activator. 5th Int Soc Thrombosis and Haemostasis, 331 Abs., pp. 348, Paris 1975.
218. WALLEN, P. Activation of plasminogen with urokinase and tissue activator. In: Thrombosis and Urokinase. P. Paoletti and S. Sherry (Eds.), pp. 91-102, Academic Press, London, New York, San Fransisco 1977.
219. SUENSON, E. and PETERSEN, L.C. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator. Biochim Biophys Acta 870, 510-519, 1986.
220. HALVORSEN, S, SKJONSBERG, O.H. and GODAL, H.C. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation. Blood Coagul Fibrinol 4, 133-137, 1993.
221. SORIA, J., SORIA, C, BERTRAND, O., MIRHSAKI, M., DUNN, R.W., SUENSON, E., DESVIGNES, P., BONNET, P., SAMAMA, M. and CAEN, J.P. Role of fibrin polymerization in fibrinolysis: Comparison between polymerizable and unpolymerizable fibrins in the potentiating effect of plasminogen activation by tissue-type plasminogen activator (t-PA). In: Fibrinogen-fibrin formation and fibrinolysis. Vol. 4. D. Lane, A. Henschen and M.K. Jasani (Eds), pp 153-158. Walter de Gruyter & Co, Berlin-New York 1986.
222. NORRMAN, B., POHL, G., JÖRNVALL, H. and WALLEN, P. Proteolytically induced variations in the enzymatic properties of tissue plasminogen activator. Activations, inactivations and reactivations. Eur J Biochem 159, 7-13, 1986.
223. NORRMAN, B., WALLEN, P. and RANBY, M. Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. Eur J Biochem 149, 193-200, 1985.
224. FLEURY, V. and ANGLES-CANO, E. Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines. Biochemistry 30, 7630-7638, 1991.
225. SCHIELEN, W.J.G., VOSKUILEN, M., TESSER, G.I. and NIEUWENHUIZEN, W. The sequence Aa-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies. Proc Natl Acad Sci USA 86, 8951-8954, 1989.
226. 152Val of the fibrinogen A a chain in the fibrin-induced rate enhancement of the plasminogen activation by t-PA. Fibrinolysis 7, 63-67, 1993.
227. YONEKAWA, O., VOSKUILEN, M. and NIEUWENHUIZEN, W. Localization in the fibrinogen Y_cnam of a new Slte tnat 1S involved in the acceleration of the tissue-type plasminogen activator-catalyzed activation of plasminogen. Biochem J 2 83, 187-191, 1992.
228. HADDELAND, U., SLETTEN, K., BENNICK, A., NIEUWENHUIZEN, W. and BROSSTAD, F. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalyzed plasminogen activation. Thromb Haemost 75, 326-331, 1996.
229. HADDELAND, U., SLETTEN, K., BENNICK, A. and BROSSTAD, F. Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue plasminogen activator-catalyzed conversion of plasminogen to plasmin. Blood Coag Fibrinol 5, 575-581, 1994.
230. RADCLIFFE, R. and HEINZE, T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: A possible additional role for plasminogen activator? Arch Biochem Biophys 211, 750-761, 1981.
231. SOEDA, S., SHIMENO, H. and NAGAMATSU, A. A comparison of bovine serum albumins, modified with a variety of carboxyl group agents, as stimulators of tissue-type plasminogen activator catalyzed activation of plasminogen. Chem Pharm Bull 37, 723-728, 1989.
232. CHMIELEWSKA, J., RANBY, M. and WIMAN, B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 31, 427-436, 1983.
233. YAMAMOTO, C, KAJI, T., SAKAMOTO, M., KOZUKA, H. and KOIZUMI, F. Calcium regulation of plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb Res 74, 163-168, 1994.
234. LIU, C.Y., WALLEN, P. and HANDLEY, D. Preparation of active iodinated and gold-labelled tissue plasminogen activator and its binding to fibrin and endothelial cells. Thromb Haemost 54, pp.60, 1985.
235. HAJJAR, K.A., HAMEL, N.M., HARPEL, P.C. and NACHMAN, R.L. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 80, 1712-1719, 1987.
236. CHENG, X.-F., BÄCK, O., NILSSON, T.K., NYLANDER-LUNDQUIST, E., POHL, G. and WALLEN, P. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as ligand. Biochem J 287, 407-413, 1992.
237. HAJJAR, K.A. and JACOVINA, A.T. Molecular cloning of an endothelial cell tissue plasminogen activator/plasminogen receptor: Annexin Il-related protein. Thromb Haemost 69, pp. 989, 1601Abs., 1993.
238. SOBERANO, M.E., ONG, E.B., JOHNSON, A.J., LEVY, M. and SCHOELLMANN, G. Purification and characterization of two forms of urokinase. Biochim Biophys Acta 445, 163-113, 1976.
239. STUMP, D.C., LÜNEN, H.R. and COLLEN, D. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures. J Biol Chem 261, 1274-1278, 1986.
240. COLLEN, D., STASSEN, J.M., BLABER, M., WINKLER, M. and VERSTRAETE, M. Biological and thrombolytic properties of proenzyme and active forms of human urokinase-III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Thromb Haemostas. 52, 27-30, 1984.
241. GUREWICH, V., PANNELL, R., LOUIE, S., KELLEY, P., SUDDITH, R.L. and GREENLEE, R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urolinase): A study in vitro and in two animal species. J Clin Invest 73, 1731-1739, 1984.
242. LOEWY, A.G., SANTER, U.V., WIECZOREK, M., BLODGETT, J.K., JONES, S.W. and CHERONIS, J.C. Purification and characterization of a novel zinc-proteinase from cultures of Aeromonas hydrophila. J Biol Chem 268, 9071-9078, 1993.
243. PANNELL, R. and GUREVICH, V. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Blood 67, 1215-1223, 1986.
244. PLOW, E.F. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest 69, 564-572, 1982.
245. BACH-GANSMO, E.T., HALVORSEN, S., GODAL, H.C. and SKJONSBERG, O.H. Impaired clot lysis in the presence of human neutrophil elastase. Thromb Res 80, 153-159, 1995.
246. YAMAMOTO, J., ISHII, I., OKADA, Y., YAMASHITA, T., RIDLER, CD., GOROG, P. and KOVACS, LB. Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitro. Thromb Res 71, 281-287, 1993.
247. BINI, A., ITOH, Y., KUDRYK, B.J. and NAGASE, H. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (Stromelysin 1): Hydrolysis of yGLY404-ALA405 peptide bond. Circulation 92, 2986, 1995.
248. RETZIOS, A.D. and MARKLAND, F.S. Fibrinolytic enzymes from the venoms of Agkistrodon Contortrix Contortrix and Crotalus Basilicus Basilicus: Cleavage site specificity towards the a-chain of fibrin. Thromb Res 74, 355-367, 1994.
249. ROBBINS, K.C. and MARKUS, G. The interaction of human plasminogen with streptokinase. In: Fibrinolysis. P.J. Gaffney and S. Balkuv-Ulutin (Eds.), pp. 61-75. Academic Press, London, New York, San Fransisco 1978.
250. TAKADA, A., MOCHIZUKI, K. and TAKADA, Y. Further characterization of SK-potentiators of plasminogen. Thromb Res 19, 485-492, 1980.
251. TAKADA, A. TAKADA, Y. and SUGAWARA, Y. The activation of Glu-and Lys-plasminogen by streptokinase: Effects of fibrin, fibrinogen and their degradation products. Thromb Res 37, 465-475, 1985.
252. HISHIKAWA-ITOH, Y., SUGIE, I., KATO, H. and IWANAGA, S. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product. J Biochem 92, 1129-1140, 1982.
253. MATSUO, O., OKADA, K., FUKAO, H. TOMIOKA, Y., UESHIMA, S., WATANUKI, M. and SAKAI, M. Thrombolytic properties of staphylokinase. Blood 76, 925-929, 1990.
254. OKADA, K., NONAKA, T., MATSUMOTO, H., FUKAO, H., UESHIMA, S. and MATSUO, O. Effects of o^-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex. Thromb Res 76, 211-220, 1994.
255. LÜNEN, H.R., VAN HOEF, B., MATSUO, O. and COLLEN, D. On the molecular interactions between plasminogen-staphylokinase, oc2-antiplasmin and fibrin. Biochim Biophys Acta 1118, 144-148, 1992.
256. SILENCE, K., COLLEN, D. and LÜNEN, R. Regulation by cc2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Blood 82, 1175-1183, 1993.
257. HESSEL, B. On the structure of the COOH-terminal part of the A a chain of human fibrinogen. Thromb Res 7, 75-87, 1975.
258. DU, X., PLOW, E.F., FRELINGER, A.L. III, OTOOLE, T.E., LOFTUS, J.C. and GINSBERG, M.H. Ligands "activate" integrin allbp3 (platelet GPIIb-IIIa). Cell 65, 409-416, 1991.
259. SAKHAROV, D.V. and RIJKEN, D.C. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 92, 1883-1890, 1995.
260. SAKHAROV, D.V., NAGELKERKE, J.F. and RIJKEN, D. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. J Biol Chem 271, 2133-2138, 1996.
261. THOMPSON, W.D., CAMPBELL, R. and EVANS, A.T. Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J Pathol 145, 27-37, 1985.
262. THOMPSON, W.D., SMITH, E.B., STIRK, CM., MARSHALL, F.I., STOUT, A.J. and KOCHHAR, A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 168, 47-53, 1992.
263. SMITH, E.B. and THOMPSON, W.D. Fibrin as a factor in atherogenesis. Thromb Res 73, 1-19, 1994.
264. KERN, D.F., SALDEEN, K., SALDEEN, T. and MALIK, A.B. Pulmonary vascular effects of a fibrin(ogen)-derived vasoactive peptide. Thromb Res 42, 783-788, 1986.
265. NICHOLS, W.W., MEHTA, J., WARGOVICH, T., SALDEEN, K., WALLIN, R. and SALDEEN, T. Fibrin(ogen)-derived peptide Bp3 0-43 increases coronary blood flow in the anesthetized dogs. Thromb Res 38, 223-229, 1985.
266. SALDEEN, K., NICHOLS, W., LAWSON, D., ANDERSSON, R., SALDEEN, T. and MEHTA, J. Fibrin(ogen) degradation product peptide 6A increases femoral artery blood flow in dogs. Acta Physiol Scand 142, 339-344, 1991.
267. BOUTCHER, P.A., GAFFNEY, P.J., RAUT, S., O’REGAN, R.G. and McLUGHLIN, P. Effects of early plasmin digests of fibrinogen on isometric tension development in isolated rings of rat pulmonary artery. Thromb Res 81, 231-239, 1996.
268. OUIMET, H. and LOSCALZO, J. Fibrinolysis. In: Thrombosis and Haemorrhage. J. Loscalzo and J.A. Shafer (Eds), pp. 127-143, Blackwell Sci Publ, London 1994.
269. MOROI, M. and AOKI, N. Isolation and characterization of «2-antiplasmin inhibitor from human plasma. J Biol Chem 251, 5956-5965, 1976.
270. COLLEN, D. Identification and some properties of a new fast reacting plasmin inhibitor in plasma. Eur J Biochem 69, 209-216, 1976.
271. WIMAN, B. and COLLEN, D. Molecular mechanism of physiological fibrinolysis. Nature 272, 549-550, 1978.
272. MIMURO, J., KIMURA, S. and AOKI, N. Release of cx2-antiplasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. J Clin Invest 77, 1006-1013, 1986.
273. KIMURA, S. and AOKI, N. Cross-linking site in fibrinogen for oc2-antiplasmin inhibitor. J Biol Chem 261, 15591-15595, 1986.
274. VAN GIEZEN, J.J.J., MINKEMA, J., BOUMA, B.N. and JANSEN, J.W.C.M. Cross-linking of a2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences. Blood Coagul Fibrinol 4, 869-875, 1993.
275. HEVESSY, Z., HARAMURA, G., BODA, Z., UDVARDY, M. and MUSZBEK, L. Promotion of the crosslinking of fibrin and ct2-antiplasmin by platelets. Thromb Haemostas 75, 161-167, 1996.
276. OKAMOTO, S. and OKAMOTO, U. Amino-methyl-cyclohexane-carboxylic acid: AMCHA; a new patent inhibitor of the fibrinolysis. Keio J Med 11, 105-115, 1962.
277. KRISHNAMURTI, C, VUKELJA, S.J. and ALVING, B.M. Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis. Thromb Res 73, 419-430, 1994.
278. WANAKA, K., OKAMOTO, S., HO RIE, N., HIJAKA-OKUNOMIYA, A.K., OKAMOTO, U., NAITO, T., OHNO, N., BOHGAKI, M., TSUDA, Y. and OKADA, Y. Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actions. Thromb Res 82, 79-86, 1996.
279. McLEAN, J.W., TOMLINSON, J.E., KUANG, W.-J., EATON, D.L., CHEN, E.Y., FLESS, G.M., SCANU, A.M. and LAWN, R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137, 1987.
280. HARPEL, P.C., GORDON, B.R. and PARKER, T.S. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA 86, 3847-3851, 1989.
281. ROUY, D., GRAILHE, P., NIGON, F., CHAPMAN, J. and ANGLÉS-CANO, E. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. Arteroscler Thromb 11, 629-638, 1991.
282. ROUY, D., KOSCHINSKY, M.L., FLEURY, V., CHAPMAN, J. and ANGLÉS-CANO, E. Apolipoprotein(a) and plasminogen interactions with fibrin: A study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry 31, 6333-6339, 1992.
283. EDELBERG, J.M., GONZALEZ-GRONOW, M. and PIZZO, S.V. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thromb Res 57, 155-162, 1990.
284. LOSCALZO, J., WEINFELD, M., FLESS, G.M. and SCANU, A.M. Lipoprotein(a), fibrin binding, and plasminogen activation. Arterioscler 76, 240-245, 1990.
285. AZNAR, J., ESTELLÉS, A., BRETO, M. and ESPAÑA, F. Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a). Thromb Res 72, 459-465, 1993.
286. GODAL, H.C. The effect of EDTA on human fibrinogen and its significance for the coagulation of fibrinogen with thrombin. Scand J Clin Lab Invest 72, Suppl. 53, 1-20, 1960.
287. BLOMBÄCK, B., BLOMBÄCK, M., LAURENT, T.C. and PERTOFT, H. Effect of EDTA on fibrinogen. Biochim Biophys Acta 727, 560-562, 1966.
288. LY, B. and GODAL, H.C. Denaturation of fibrinogen, the protective effect of calcium. Haemostasis 7, 44-51, 1972.
289. HAVERKATE, F. and TIMAN, G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. Thromb Res 10, 803-812, 1977.
290. MARGUERIE, G., CHAGNIEL, G. and SUSCILLON, M. The binding of calcium to bovine fibrinogen. Biochim Biophys Acta 490, 94-103, 1977.
291. NIEUWENHUIZEN, W., van RUIJVEN-VERMEER, I.A.M., NOOIJEN, W.J., VERMOND, A., HAVERKATE, F. and HERMANS, J. Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. Thromb Res 22, 653-657, 1981.
292. NIEUWENHUIZEN, W., VERMOND, A. and HERMANS, J. Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrin(ogen). Thromb Res 31, 81-86, 1983.
293. HÖRMANN, H. Interaction with Fibrinogen and Fibrin. In: Plasma Fibronectin. J. McDonagh (Ed.), Vol. 5, pp. 99-120, Marcel Dekker Inc., New York, Basel 1985.
294. MOSHER, D.F. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 250, 6614-6621, 1975.
295. MOSHER, D.F. Action of fibrin-stabilizing factor on cold-insoluble globuliin and OC2-macroglobulin in clotting plasma. J Biol Chem 257, 1639-1645, 1976.
296. IWANAGA, S., SUZUKI, K. and HASHIMOTO, S. Bovine plasma cold-insoluble globulin: gross structure and function. Ann NY Acad Sci 312, 56-73, 1978.
297. McDONAGH, R.P., McDONAGH, J., PETERSEN, T.E., THOGERSEN, H.C, SKORSTENGAARD, K., SOTTRUP-JENSEN, L. and MAGNUSSON, S. Amino acid sequence of the factor XHIa acceptor site in bovine plasma fibronectin. FEBS Lett 727, 174-178, 1981.
298. EHRLICH, P.H., SOBEL, J.H., MOUSTAFA, Z.A. and CANFIELD, R.E. Monoclonal antibodies to a-chain regions of human fibrinogen that participate in polymer formation. Biochemistry 22, 4184-4192, 1983.
299. PROCYK, R., BISHOP, P.D. and KUDRYK, B. Fibrin-recombinant human factor XIII. A subunit association. Thromb Res 77, 127-138, 1993.
300. HORNYAK, T.J. and SHAFER, J.A. Interactions of factor XIII with fibrin as substrate and cofactor. Biochemistry 31, 423-429, 1992.
301. GREENBERG, C.S. and SHUMAN, M.A. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. J Biol Chem 257, 6096-6101, 1982.
302. MARY, A., ACHYUTHAN, K.E. and GREENBERG, C.S. Factor XIII binds to the Aa-and Bp-chains in the D-domain of fibrinogen: An immunoblotting study. Biochem Biophys Res Comm 147, 608-614, 1987.
303. FUKUE, H., ANDERSON, K., McPHEDRAN, P., CLYNE, L. and McDONAGH, J. A unique factor XIII inhibitor to a fibrin-binding site on factor XHIa. Blood 79, 65-74, 1992.
304. PEDERSEN, L.C, YEE, V.C, BISHOP, P.D., Le TRONG, I., TELLER, D.C and STENKAMP, R.E. Transglutaminase factor XIII uses proteinase-like catalytic triad to cross link macromolecules. Protein Science 3, 1131-1135, 1994.
305. MICANOVIC, R., PROCYK, R., LIN, W. and MATSUEDA, G.R. Role of histidine 373 in the catalytic activity of coagulation factor XIII. J Biol Chem 269, 9190-9194, 1994.
306. YEE, V.C, PEDERSEN, L.C, Le TRONG, I., BISHOP, P.D., STENKAMP, R.E. and TELLER, D.C. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91, 7296-7300, 1994.
307. LORAND, L., CREDO, R.B. and JANUS, T.J. Factor XIII (Fibrin stabilizing factor). Meth Enzymol 80C, 333-341, 1981.
308. De BACKER-ROYER, C. and MEUNIER, J.-C Effect of temperature and pH on factor XHIa from human placenta. Int J Biochem 24, 637-642, 1992.
309. +2-related regulatory function of fibrinogen. Proc Natl Acad Sci USA 75, 4234-4237, 1978.
310. BULUK, K., JANUSZKO, T. and OLBROMSKI, J. Conversion of fibrin to desmofibrin. Nature, 191, 1093-1094, 1961.
311. GREENBERG, C.S., ACHYUTAN, K.E. and FENTON, J.W. II. Factor XHIa formation promoted by complexing of a-thrombin, fibrin and plasma factor XIII. Blood 69, 867-871, 1987.
312. GREENBERG, C.S., ACHYUTHAN, K.E., RAJAGOPALAN, S. and PIZZO, S.V. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. Arch Biochem Biophys 262, 142-148, 1988.
313. NASKI, M.C, LORAND, L. and SHAFER, J.A. Characterization of the kinetic pathway for fibrin promotion of cc-thrombin-catalyzed activation of plasma factor XIII. Biochemistry, 30, 934-941, 1991.
314. CREDO, R.B., CURTIS, C.G. and LORAND, L. cc-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor Xllla). Calcium ion regulatory aspects. Biochemistry 20, 3770-3778, 1981.
315. YEE, V.C, PEDERSEN, L.C, BISHOP, P.D., STENKAMP, R.E. and TELLER, D.C. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res 78, 389-397, 1995.
316. HAWIGER, J. Adhesive interactions of platelets and their blockade. Ann NY Acad Sci 614, 270-278, 1991.
317. PEERSCHKE, E.B. The platelet fibrinogen receptor. Semin Hematol XXII, 241-259, 1985.
318. VU, T.-K.H., HUNG, D.T., WHEATON, V.I. and COUGHLIN, S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068, 1991.
319. 2+ mobilization. FEBS Lett 288, 123-128, 1991.
320. STORCK, J., KUSTERS, B. and ZIMMERMANN, E.R. The tethered ligand receptor is the responsible receptor for the thrombin induced release of von Willebrand factor from endothelial cells (HUVEC). Thromb Res 77, 249-258, 1995.
321. DERIAN, C.K., SANTULLI, R.J., TOMKO, K.A., HAERTLEIN, B.J. and ANDRADE-GORDON, P. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb Res 78, 505-519, 1995.
322. MUSTARD, J.F., PACKHAM, M.A., KINLOUGH-RATHBONE, R.L., PERRY, D.W. and REGOECZI, E. Fibrinogen and ADP-induced platelet aggregation. Blood 52, 453-466, 1978.
323. MARGUERIE, G.A., PLOW, E.F. and EDGINGTON, T.S. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 254, 5357-5363, 1979.
324. TOMIKAWA, M., IWAMOTO, M., SODERMAN, S. and BLOMBACK, B. Effect of fibrinogen on ADP-induced platelet aggregation. Thromb Res 19, 841-855, 1980.
325. NIEWIAROWSKI, S., KORNECKI, E., BUDZYNSKI, A.Z., MORINELLI, T.A. and TUSZYNSKI, G.P. Fibrinogen interaction with platelet receptors. Ann NY Acad Sci 408, 536-555, 1983.
326. COLLER, B.S., PEERSCHKE, E.I., SCUDDER, L.E. and SULLIVAN, CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombastenic-like state in normal platelets and binds to glycoproteins lib and/or Ilia. J Clin Invest 72, 325-338, 1983.
327. HAWIGER, J. and TIMMONS, S. Binding of fibrinogen and von Willebrand factor to platelet glycoprotein IIb-IIIa complex. In: Platelets: receptors, adhesion, secretion. J.J. Hawiger (Ed). Methods in Enzymology. Vol. 215 B, pp 228-243, Academic Press, Inc., New York?? 1992.
328. KLOCZEWIAK, M., TIMMONS, S. AND HAWIGER, J. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the y chain of human fibrinogen and is not involved in the fibrin polymerization reaction. Thromb Res 29, 249-255, 1983.
329. KLOCZEWIAK, M., TIMMONS, S., LUKAS, T.J. and HAWIGER, J. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the y chain. Biochemistry 23, 1767-1774, 1984.
330. KLOCZEWIAK, M., TIMMONS, S., BEDNAREK, M.A., SAKON, M. and HAWIGER, J. Platelet receptor recognition domain on the y-chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 28, 2915-2919, 1989.
331. PLOW, E.F., PIERSCHBACHER, M.D., RUOSLAHTI, E., MARGUERIE, G.A. and GINSBERG, M.H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 82, 8057-8061, 1985.
332. FARRELL, D.H., THIAGARAJAN, P., CHUNG, D.W. and DAVIE, E.W. Role of fibrinogen a and y chain sites in platelet aggregation. Proc Natl Acad Sci USA 89, 10729-10732, 1992.
333. FARRELL, D.H. and THIAGARAJAN, P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 269, 226-231, 1994.
334. HARFENIST, E.J., PACKHAM, M.A. and MUSTARD, J.F. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits and rats. Blood 71, 132-136, 1988.
335. VERHALLEN, P.F.J, and BARTH, M. Species comparison of anti-aggregatory properties of three fibrinogen receptor-antagonists: RGDS, echistatin and the carboxyterminal dodecapeptide of the fibrinogen gamma chain. Thromb Haemost 65, pp. 1144, 1613Abs., 1991.
336. JOLLES, P., LOUCHEUX-LEFEBVRE, M.H. and HENSCHEN, A. Structural relatedness of k-casein and fibrinogen y-chain. J Mol Evol 11, 271-277, 1978.
337. JOLLES, P., LÉVY-TOLEDANO, S., FIAT, A.-M., SORIA, C, GILLESSEN, D., THOMAIDIS, A., DUNN, F.W. and CAEN, J.P. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from k-casein on platelet function. Eur J Biochem 158, 379-382, 1986.
338. BAL dit SOLLIER, C, DROUET, L., PIGNAUD, G., CHEVALLIER, C, CAEN, J., FIAT, A.-M., IZQUIERDO, C. and JOLLES, P. Effect of k-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Thromb Res 81, 427-437, 1996.
339. CALVETE, J.J., ARIAS, J., ALVAREZ, M.V., LOPEZ, M.M., HENSCHEN, A. and GONZALEZ-RODRIGUEZ, J. Further studies on the topography of the N-terminal region of human platelet glycoprotein Ilia. Biochem J 274, 457-463, 1991.
340. CALVETE, J.J., ARIAS, J., ALVAREZ, M.V., LOPEZ, M.M., HENSCHEN, A. and GONZALEZ-RODRIGUEZ, J. Further studies on the topography of human platelet glycoprotein lib. Biochem J 273, 767-775, 1991.
341. SORIA, J., SORIA, C, BERTRAND, O. and SAMAMA, M. Fibrinogen and platelet aggregation. Role of the glycopeptidic part and of the fibrinopeptide B. Description of a new technique of fibrinoglycopeptide isolation. Biochem Biophys Res Comm 82, 442-450, 1978.
342. STANFORD, M.F., MUNOZ, P.C. and VROMAN, L. Platelets adhere where flow has left fibrinogen on glass. Ann NY Acad Sci 416, 504-512, 1983.
343. NAGAI, H., HANDA, M., KAWAI, Y., WATANABE, K. and IKEDA, Y. Evidence that plasma fibrinogen and platelet membrane GPIIb-Illa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Thromb Res 71, 467-477, 1993.
344. TOMIKAWA, M., IWAMOTO, M., OLSSON, P., SODERMAN, S. and BLOMBACK, B. On the platelet-fibrinogen interaction. Thromb Res 19, 869-876, 1980.
345. COLLER, B.S. Interaction of normal, thrombasthenic and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombastehemia. Blood 55, 169-178, 1980.
346. GARTNER, T.K., AMRANI, D.L., DERRICK, J.M., KIRSCHBAUM, N.E., MATSUEDA, G.R. and TAYLOR, D.B. Characterization of adhesion of "resting" and stimulated platelets to fibrinogen and its fragments. Thromb Res 71, 47-60, 1993.
347. CALVETE, J.J., SCHAFER, W., MANN, K., HENSCHEN, A. and GONZALEZ-RODRIGUEZ, J. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein Ilb/IIIa. Influence of peptide length. Biochemistry 206, 759-765, 1992.
348. D’SOUZA, S.E., GINSBERG, M.H., BURKE, T.A. and PLOW, E.F. The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its a subunit. J Biol Chem 265, 3440-3446, 1990.
349. D’SOUZA, S.E., GINSBERG, M.H., MATSUEDA, G.R. and PLOW, E.F. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 350, 66-68, 1991.
350. SHAHBAZI, T., JONES, N., RADOMSKI, M.W., MORO, M.A. and GINGELL, D. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin. Thromb Res 75, 631-642, 1994.
351. MENDELSOHN, M.E., O’NEILL, S., GEORGE, D. and LOSCALZO, J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetyl cystine. J Biol Chem 265, 19028-19034, 1990.
352. RADOMSKI, M.W., REES, D.D., DUTRA, A. and MONCADA, S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 107, 745-749, 1992.
353. GARTNER, T.K., GERRARD, J.M., WHITE, LG. and WILLIAMS, D.C. The endogenous lectin of human platelet is an a-granule component. Blood 58, 153-157, 1981.
354. MOSHER, D.F., DOYLE, M.J. and JAFFE, E.A. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell "feiol 93, 343-348, 1982.
355. LEUNG, L.L.K, and NACHMAN, R.L. Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest 70, 542-549, 1982.
356. TUSZYNSKI, G.P., SRIVASTAVA, S., SWITALSKA, H.I., HOLT, J.C., CIERNIEWSKI, C.S. and NIEWIAROWSKI, S. The interaction of human platelet thrombospondin with fibrinogen. J Biol Chem 260, 12240-12245, 1985.
357. BACON-BAGULEY, T., KUDRYK, B.J. and WALZ, D.A. Thrombospondin interaction with fibrinogen. Evidence for binding to the A alpha-and B beta-chains of fibrinogen. J Biol Chem 262, 1927-1930, 1987.
358. AGAM, G., GARTNER, T.K. and LEVIN, A. Inhibition of platelet aggregation and lectin activity by oligamines. Thromb Res 33, 245-257, 1984.
359. SATOH, S., TAKAHASHI, K. and SAKURAGAWA, N. Thrombospondin is an agglutinin of platelets. Thromb Res 72, 509-517, 1993.
360. BLOMBÄCK, B. Alfred L. Copley-The scientist and his contributions to our understanding of haemostasis, thrombosis and atherogenesis. Thromb Res 66, 3-10, 1992.
361. ALVING, B.M., CHUNG, S.I., MURANO, G., TANG, D.B. and FINLAYSON, J.S. Rabbit fibrinogen: time course of constituent chain production in vivo. Arch Biochim Biophys 277, 1-9, 1982.
362. VAN DE STOLPE, A., JACOBS, N., HAGE, W.J., TERTOOLEN, L., VAN KOOYK, Y., NOVAKOVA, I.R.O. and de WITTE, T. Fibrinogen binding to ICAM-1 on EA.hy926 endothelial cells is dependent on an intact cytoskeleton. Thromb Haemost 75, 182-189, 1996.
363. DEJANA, E., ZANETTI, A. and CONFORTI, G. Biochemical and functional characteristics of fibrinogen interaction with endothelial cells. Haemostasis 18, 262-270, 1988.
364. ALTIERI, D.C, BADER, R., MANNUCCI, P.M. and EDGINGTON, T.S. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 707, 1893-1900, 1988.
365. LANGUINO, L.R., DUPERRAY, A., JOGANIC, K.J., FORNARO, M., THORNTORN, G.B. and ALTIERI, D.C. Regulation of leucocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 92, 1505-1509, 1995.
366. LEVEN, R.M., SCHICK, P.K. and BUDZYNSKI, A.Z. Fibrinogen biosynthesis in isolated guinea pig megakaryocytes. Blood 65, 501-504, 1985.
367. ODDOUX, C. and GRIENINGER, G. Fibrinogen assembly: Insights from chicken hepatocytes. Hepatology 19, 688-693, 1994.
368. UZAN, G., COURTOIS, G., STANKOVIC, Z., CRABTREE, G.R. and MARGURIE, G. Expression of the fibrinogen genes in rat megakaryocytes. Biochem Biophys Res Commun 140, 543-549, 1986.
369. SHIMIZU, A., SAITO, Y. and INADA, Y. Distinctive role of histidine-16 of the Bß chain of fibrinogen in the end-to-end association of fibrin. Proc Natl Acad Sci USA 83, 591-593, 1986.
370. DOOLITTLE, R.F., TAKAGI, T. and COTTRELL, B.A. Platelet and plasma fibrinogens are identical gene products. Science 185, 368-370, 1974.
371. GALANAKIS, D.K., LANE, B.P. and SIMON, S.R. Albumin modulates lateral assembly of fibrin polymers: Evidence of enhanced fine fibril formation and of unique synergism with fibrinogen. Biochemistry 26, 2389-2400, 1987.
372. MOSESSON, M.W., DiORIO, J.P., SIEBENLIST, K.R., WALL, J.S. and HAINFELD, J.F. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction. Blood 82, 1517-1521, 1993.
373. BUNCE, L.A., SPORN, L.A. and FRANCIS, C.W. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the ß chain. J Clin Invest 89, 842-850, 1992.
374. ERBAN, J.K. and WAGNER, D.D. A 130-kDa protein on endothelial cells binds to amino acids 15-42 of the Bß chain of fibrinogen. J Biol Chem 267, 2451-2458, 1992.
375. CHUNG, D.W., HARRIS, J.E. and DAVIE, E.W. Nucleotide sequences of the three genes coding for human fibrinogen. In: Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. Advances in Experimental Medicine and Biology. Vol. 281. C.Y. Liu and S. Chien (Eds), pp. 39-48, Plenum Press, New York 1990.
376. BLOMBÄCK, B., PROCYK, R., ADAMSON, L. and HESSEL, B. Factor XIII induced gelation of human fibrinogen-An alternative thiol enhanced, thrombin independent pathway. Thromb Res 37, 613-628, 1985.
377. BLOMBÄCK, B., BANERJEE, D., CARLSSON, K., HAMSTEN, A., HESSEL, B., PROCYK, R., SILVEIRA, A. and ZACHARSKI, L. Native fibrin gel networks and factors influencing their formation in health and disease. In: Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. C.Y. Liu and S. Chien (Eds), pp. 1-23, Plenum Press, New York 1990.
378. OLAISEN, B., TEISBERG, P. and GEDDE-DAHL, T., Jr. Fibrinogen y chain locus is on chromosome 4 in man. Hum Genet 61, 24-26, 1982.
379. KANT, J.A., FORNACE, A.J. Jr, SAXE, D., SIMON, M.I., McBRIDE, O.W. and CRABTREE, G.R. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc. Natl. Acad. Sci. USA 82, 2344-2348, 1985.
380. PROCYK, R., ADAMSON, L. BLOCK, M. and BLOMBÄCK, B Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers-a thiol enhanced process. Thromb Res 40, 833-852, 1985.
381. PROCYK, R. and BLOMBÄCK, B. Factor XHI-induced crosslinking in solutions of fibrinogen and fibronectin. Biochim Biophys Acta 967, 304-313, 1988.
382. CRABTREE, G.R., COMEAU, CM., FOWLKES, D.M., FORNACE, A.J. Jr., MALLEY, J.D. and KANT, J.A. Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? J Mol Biol 185, 1-19, 1985.
383. HENRY, I., UZAN, G., WEIL, D., NICOLAS, H. KAPLAN, J.C, MARGUERIE, C, KAHN, A. and JUNIEN, C. The genes coding for A a, B ß, and y-chains of fibrinogen Map to 4q2. Am J Hum Genet 36, 760-768, 1984.
384. NICKERSON, J.M. and FULLER, G.M. In vitro synthesis of rat fibrinogen: Identification of preAoc, preBß, and prey polypeptides. Proc Natl Acad Sci USA 78, 300-307, 1981.
385. YU, S., SHER, B., KUDRYK, B. and REDMAN, CM. Intracellular assembly of human fibrinogen. J Biol Chem 258, 13407-13410, 1983.
386. YU, S., SHER, B., KUDRYK, B. and REDMAN, CM. Fibrinogen procursors. Order of assembly of fibrinogen chains. J Biol Chem 259, 10574-10581, 1984.
387. YU, S., KUDRYK, B. and REDMAN, C. A scheme for the intracellular assembly of human fibrinogen. In: Fibrinogen-Fibrin formation and Fibrinolysis. Vol. 4. D.A. Lane, A. Henschen and M.K. Jasani (Eds.), pp. 3-13, Walter de Gruyter Co., Berlin-New York 1986.
388. GRIENINGER, G., HERZBERG, K.M. and PINDYCK, J. Fibrinogen synthesis in serum-free hepatocyte cultures: Stimulation by glucocorticoids. Proc Natl Acad Sci USA 75, 5506-5510, 1978.
389. CRABTREE, G.R. and KANT, J.A. Coordinate accumulation of the mRNAs for the a, ß, and y chains of rat fibrinogen following defibrination. J Biol Chem 257, 7277-7279, 1982.
390. NESBITT, J.E. and FULLER, G.M. Transcription and translation are required for fibrinogen mRNA degradation in hepatocytes. Biochim Biophys Acta 1089, 88-94, 1991.
391. OTTO, J.M., GRENETT, H.E. and FULLER, G.M. The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J Cell Biol 105, 1067-1072, 1987.
392. PLANT, P.W. and GRIENINGER, G. Noncoordinate synthesis of the fibrinogen subunits in hepatocytes cultured under hormone-deficient conditions. J Biol Chem 261, 2331-2336, 1986.
393. KUDRYK, B., OKADA, M., REDMAN, CM. AND BLOMBÄCK, B. Biosynthesis of dog fibrinogen: Characterization of nascent fibrinogen in the rough endoplasmic reticulum. Eur J Biochem 125, 673-682, 1982.
394. HIROSE, S., ODA, K. AND IKEHARA, Y. Tyrosine O-sulfation of the fibrinogen yB chain in primary cultures of rat hepatocytes. J Biol Chem 263, 7426-7430, 1988.
395. YU, S., KONG, V., KUDRYK, B. and REDMAN, CM. Endogenous forms of fibrinogen in Hep G2 cells. Thromb Res 46, 281-293, 1987.
396. ROY, S., MUKHOPADHYAY, G. and REDMAN, CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with Bß cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 265, 6389-6393, 1990.
397. ROY, S., YU, S., BANERJEE, D., OVERTON, O., MUKHOPADHYAY, G., ODDOUX, C, GRIENINGER, G. and REDMAN, CM. Assembly and secretion of fibrinogen. Degradation of individual chains. J Biol Chem 267, 23151-23158, 1992.
398. ROY, S., OVERTON, O. and REDMAN, C. Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 269, 691-695, 1994.
399. ROY, S., PROCYK, R., KUDRYK, B.J. and REDMAN, C. Assembly and secretion of recombinant human fibrinogen. J Biol Chem 266, 4758-4763, 1991.
400. HARTWIG, R. and DANISHEFSKY, K.J. Studies on the assembly and secretion of fibrinogen. J Biol Chem 266, 6578-6585, 1991.
401. BINNIE, CG., HETTASCH, J.M., STRICKLAND, E. and LORD, S.T. Characterization of purified recombinant fibrinogen: Partial phosphorylation of fibrinopeptide A. Biochemistry 32, 107-113, 1993.
402. ROY, S., KUDRYK, B. and REDMAN, CM. Secretion of biologically active recombinant fibrinogen by yeast. J Biol Chem 270, 23761-23767, 1995.
403. NEEDHAM, A.E. Haemostatic mechanisms in invertebrata. In: The haemostatic mechanism in man and other animals. Symposia of the Zoological Society of London, Nr. 27. R.G: Macfarlane (Ed.), pp 19-44, Academic Press 1970.
404. IWANAGA, S., MI ATA, T., TOKUNAGA, F. and MUTA, T. Molecular mechanism of hemolymph clotting system in Limulus. Thromb Res 68, 1-32, 1992.
405. FULLER, G.M. and DOOLITTLE, R.F. Studies of invertebrate fibrinogen. II. Transformation of lobster fibrinogen into fibrin. Biochemistry, 10, 1311-1315, 1971.
406. DOOLITTLE, R.F. and FULLER, G.M. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis studies on lobster fibrinogen and fibrin. Biochim Biophys Acta 263, 805-809, 1972.
407. DOOLITTLE, R.F. and RILEY, M. The amino-terminal sequence of lobster fibrinogen reveals common ancestry with vitellogenins. Biochem Biophys Res Comm 167, 16-19, 1990.
408. XU, X. and DOOLITTLE, R.F. Presence of a vertebrate fibrinogen-like sequence in an echinoderm. Proc. Natl. Acad. Sci USA 87, 2097-2101, 1990.
409. WEISSBACH, L. and GRIENINGER, G. Bipartite mRNA for chicken oc-fibrinogen potentially encodes an amino acid sequence homologous to ß-and y-fibrinogens. Proc Natl Acad Sci USA 87, 5198-5202, 1990.
410. PAN, Y. and DOOLITTLE, R.F. cDNA sequence of a second fibrinogen a chain in lamprey: An archetypal version alignable with full-length ß and y chains. Proc Natl Acad Sci USA 89, 2066-2070, 1992.
411. DOOLITTLE, R.F. and BLOMBÄCK, B. Amino-acid sequence investigations of fibrinopeptides from various mammals: Evolutionary implications. Nature 202, 147-152, 1964.
412. TEGER-NILSSON, A.-C. and BLOMBÄCK, B. Rate of thrombin-fibrinogen reaction in some mammalian species. Thromb Res 5, 223-233, 1974.
413. DOOLITTLE, R.F., FENG, D.-F., TSANG, S., CHO, G. and LITTLE, E. Determining divergence times of the major Kingdoms of living organisms with a protein clock. Science 277, 470-477, 1996.
414. AL-MONDHIRY, H. and EHMANN, C.W. Congenital afibrinogenemia. Am J Hematology 46, 343-347, 1994.
415. UZAN, G., COURTOIS, G., BESMOND, C, FRAIN, M., SALA-TREPAT, J., KAHN, A. and MARGUERIE, G. Analysis of fibrinogen genes in patients with congenital afibrinogenemia. Biochem Biophys Res Comm 120, 376-383, 1984.
416. ZHENG, ZHI, ASHTON, R.W., NI, F. and SCHERAGA, H.A. Thrombin hydrolysis of an N-terminal peptide from fibrinogen Lille: Kinetic and NMR studies. Biochemistry 31, 4226-4231, 1992.
417. HIGGINS, D.L. and SHAFER, J.A. Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-Aal6 by a histidyl residue. J Biol Chem 256, 12013-12017, 1981.
418. SORIA, J., SORIA, C, SAMAMA, M., HENSCHEN, A. and SOUTHAN, C. Detection of fibrinogen abnormality in dysfibrinogenemia. Special report on fibrinogen Metz characterized by an amino acid substitution located at the peptide bond cleaved by thrombin. In: Fibrinogen-Recent Biochemical and Medical Aspects. Vol. 1. A. Henschen et al. (Eds.), pp. 129-143. W. de Gruyter & Co., Berlin, New York 1981.
419. KOOPMAN, J., HAVERKATE, F., GRIMBERGEN, J., ENGESSER, L., NOVAKOVA, I., KERST, A.F.J.A. and LORD, S.T. Abnormal fibrinogens IJmuiden (BßArgl4->Cys) and Nijmegen (BßArg44->Cys) form disulfide-linked fibrinogen-albumin complexes. Proc Natl Acad Sci USA 89, 3478-3482, 1992.
420. LIU, C.Y., KOEHN, J.A. and MORGAN, F.J. Characterization of fibrinogen New York I. A dysfunctional fibrinogen with a deletion of Bß(9-72) corresponding exactly to exon 2 of the gene. J Biol Chem 260, 4390-4396, 1985.
421. LIU, C.Y., WALLEN, P. and HANDLEY, D.A. Fibrinogen New York I. The structural, functional, and genetic defects and an hypothesis of the role of fibrin in the regulation of coagulation and fibrinolysis. In: Fibrinogen, Fibrin Formation and Fibrinolysis. Vol. 4, pp. 79-90. D.A. Lane, A. Henschen and M.K. Jasam (Eds). Walter de Gruyter, Berlin 1986.
422. KAUDEWITZ, H., HENSCHEN, A., SORIA, C. and SORIA, J., BERTRAND, O. and HEATON, D. The molecular defect of the genetically abnormal fibrinogen Christchurch II. In: Fibrinogen and its derivatives. G. Müller-Berghaus, U. Scheefers-Borchel, E. Selmayr and A. Henschen (Eds), pp 31-36. Elsevier Science Publ. BV, Amsterdam, New York-Oxford 1986.
423. SOBEL, J.H., TRAKHT, I., WU, H.Q., RUDCHENKO, S. and EGBRING, R. a-chain cross-linking in fibrin(ogen) Marburg. Blood 86, 989-1000, 1995.
424. COLLET, J. P., SORIA, J., MIRSHAHI, M., HIRSCH, M., DAGONNET, F.B., CAEN, J. and SORIA, C. Dusart Syndrome: A new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood 82, 2462-2469, 1993.
425. WADA, Y. and LORD, S.T. A correlation between thrombotic disease and a specific fibrinogen abnormality (Aa 554 Arg->Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood 84, 3709-3714, 1994.
426. CARR, M.E., Jr., BLATT, P.M., ROBERTS, H.R., BROOKER, J.Z. and HERMANS, J. Detection of an abnormal plasma clot structure by a simple rigidity assay. Thrombos Haemostas 42, 965-971, 1979.
427. HAVERKATE, F. and SAMAMA, M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 73, 151-161, 1995.
428. MENACHE, D. Constitutional and familial abnormal fibrinogen. Thromb Diath Haemorrh, Suppl. 13, 173-185, 1964.
429. HESSEL, B., SILVEIRA, A.M.V., CARLSSON, K., OKSA, H., RASI, V., VAHTERA, E., PROCYK, R. and BLOMBÄCK, B. Fibrinogenemia Tampere-A dysfibrinogenemia with defective gelation and thromboembolic disease. Thromb Res 78, 323-339, 1995.
430. DAHL, O.E., PEDERSEN, T., KIERULF, P., WESTVIK, Ä.-B., LUND, P., ARNESEN, H., SELJEFLOT, I., ABDELNOOR, M. and LYBERG, T. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 70, 451-458, 1993.
431. ERNST, E. Plasma fibrinogen-an independent cardiovascular risk factor. J Intern Med 227, 365-372, 1990.
432. FATAH, K., HAMSTEN, A., BLOMBÄCK, B. and BLOMBÄCK, M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost 68, 130-135, 1992.
433. McDONAGH, J. Suppression of plasminogen binding to fibrin by high fibrinogen: A mechanism for how high fibrinogen enhances the risk of thrombosis. CML-Thrombosis 3, II-XIX, 1993.
434. WILLIAMS, S., FATAH, K., IVERT, T. and BLOMBÄCK, M. The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coag Fibrinol 6, 718-725, 1995.
435. BJORNSSON, T.D., SCHNEIDER, D.E. and BERGER, H., Jr. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther 250, 154-161, 1989.
436. REININGER, A.J., HEINZMANN, U., REININGER, C.B., FRIEDRICH, P. and WURZINGER, L.J. Flow mediated fibrin thrombus formation in an endothelium-lined model of arterial branching. Thromb Res 74, 629-641, 1994.
437. TIPPE, A. and MÜLLER-MONHSSEN, H. Shear dependence of the fibrin coagulation kinetics in vitro. Thromb Res 72, 379-388, 1993.
438. DAVIES, M.J. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 82, 1-32, 1996.
439. FU, Y., CAO, Y., HERTZBERG, K.M. and GRIENENGER, G. Fibrinogen a genes: Conservation of bipartite transcripts and carboxy-terminal-extended a subunits in vertebrates. Genomics 30, 71-76, 1995.
440. MEH, D.A., SIEBENLIST, K.R., GALANAKIS, D.K., BERGTROM, G. and MOSESSON, M.W. The dimeric Aa chain composition of dysfibrinogenemic molecules with mutations at Aa 16. Thromb Res 78, 531-539, 1995.
441. KOOPMAN, J., HAVERKATE, F., LORD, S.T., GRIMBERGEN, J. and MANNUCCI, P.M. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of Bß68Ala-> Thr. J Clin Invest 90, 238-244, 1992.
442. KOOPMAN, J., HAVERKATE, F., GRIMBERGEN, J., EGBRING, R. and LORD, S.T. Fibrinogen Marburg: A homozygous case of dysfibrinogenemia, lacking amino acids Aa 461-610 (Lys 461 AAA->STOP TAA). Blood SO, 1972-1979, 1992.